Platelet function in patients with chronic myeloid leukemia treated with asciminib
File(s)
Author(s)
Type
Journal Article
Date Issued
2020-07-12
Date Acceptance
2020-06-30
Citation
Leukemia & Lymphoma, 2020, 61 (12), pp.3021-3023
ISSN
1042-8194
Publisher
Informa UK Limited
Start Page
3021
End Page
3023
Journal / Book Title
Leukemia & Lymphoma
Volume
61
Issue
12
Copyright Statement
© 2020 Taylor & Francis. This is an Accepted Manuscript of an article published by Taylor & Francis in
Leukemia & Lymphoma on 12 July 2020, available online: https://doi.org/10.1080/10428194.2020.1791856
Leukemia & Lymphoma on 12 July 2020, available online: https://doi.org/10.1080/10428194.2020.1791856
Identifier
https://www.tandfonline.com/doi/full/10.1080/10428194.2020.1791856
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
Hematology
BCR-ABL INHIBITOR
TYROSINE KINASE
DYSFUNCTION
PONATINIB
EFFICACY
Immunology
1103 Clinical Sciences
Publication Status
Published
Date Publish Online
2020-07-12